1. Home
  2. MESO vs THS Comparison

MESO vs THS Comparison

Compare MESO & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MESO
  • THS
  • Stock Information
  • Founded
  • MESO 2004
  • THS 2021
  • Country
  • MESO Australia
  • THS United States
  • Employees
  • MESO N/A
  • THS N/A
  • Industry
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • THS Packaged Foods
  • Sector
  • MESO Health Care
  • THS Consumer Staples
  • Exchange
  • MESO Nasdaq
  • THS Nasdaq
  • Market Cap
  • MESO 1.7B
  • THS 1.4B
  • IPO Year
  • MESO N/A
  • THS N/A
  • Fundamental
  • Price
  • MESO $12.48
  • THS $27.08
  • Analyst Decision
  • MESO Buy
  • THS Hold
  • Analyst Count
  • MESO 4
  • THS 6
  • Target Price
  • MESO $18.00
  • THS $34.83
  • AVG Volume (30 Days)
  • MESO 305.9K
  • THS 693.7K
  • Earning Date
  • MESO 02-26-2025
  • THS 05-05-2025
  • Dividend Yield
  • MESO N/A
  • THS N/A
  • EPS Growth
  • MESO N/A
  • THS N/A
  • EPS
  • MESO N/A
  • THS 0.51
  • Revenue
  • MESO $5,670,000.00
  • THS $3,354,000,000.00
  • Revenue This Year
  • MESO $228.57
  • THS $1.43
  • Revenue Next Year
  • MESO $356.77
  • THS $1.68
  • P/E Ratio
  • MESO N/A
  • THS $53.76
  • Revenue Growth
  • MESO N/A
  • THS N/A
  • 52 Week Low
  • MESO $4.60
  • THS $25.69
  • 52 Week High
  • MESO $22.00
  • THS $43.84
  • Technical
  • Relative Strength Index (RSI)
  • MESO 34.58
  • THS 34.70
  • Support Level
  • MESO $13.60
  • THS $25.69
  • Resistance Level
  • MESO $14.45
  • THS $28.56
  • Average True Range (ATR)
  • MESO 0.49
  • THS 0.86
  • MACD
  • MESO 0.02
  • THS 0.08
  • Stochastic Oscillator
  • MESO 23.50
  • THS 30.48

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

About THS Treehouse Foods Inc.

TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages and drink mixes (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.

Share on Social Networks: